Partners
Cooperating partners
ResearchGate
Cooperating conferences
17th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health - IPC2024
IPC 2024 will be held on 18th-20th June 2024 at Prague Congress Centre, Prague, Czech Republic. The goal of conference IPC 2024 is to provide a scientific forum for all stakeholders of probiotics and prebiotics and to enable the interactive exchange of state-of-the-art knowledge. The conference is focused on evidence-based benefits, health claims proven in scientific experiments and clinical trials.
New scientific evidence that supports or questions the efficiency of already existing or prospective substances and applications will be conferred. In addition, novel strains, controversial but scientifically solid ideas, approaches and visions will be presented as well.
Participants will meet those who influenced the past, influence the present and most importantly will shape the future of probiotics and prebiotics by means of basic research, clinical trials, regulatory efforts or development of industrial technology.
8th Microbiome R&D and Business Collaboration Congress: Asia
Previous conferences
4th International Conference on Food Bioactives and Health
7th Microbiome R&D and Business Collaboration Congress: Asia co-located with 6th Probiotics & Prebiotics Congress 2023
16th INTERNATIONAL SCIENTIFIC CONFERENCE ON PROBIOTICS, PREBIOTICS, GUT MICROBIOTA AND HEALTH – IPC2023
6th Microbiome R&D and Business Collaboration Congress: Asia co-located with 5th Probiotics & Prebiotics Congress and 4th Skin Microbiome & Cosmeceuticals Congress 2023
3rd Microbiome for Agriculture Congress Asia
8th Plant Genomics and Gene Editing Congress: Asia
https://www.global-engage.com/event/plant-genomics-asia/
https://www.global-engage.com/event/microbiome-agriculture-asia/
3rd Asia Skin Microbiome Congress
Over 20+ presentations addressing on host-microbe interaction, skin disease, emerging technologies, interventional and cosmetic advances, and regulatory considerations.
World Anti-Microbial Resistance Congress
09th International Conference on Food Resources and Security
Microbiome Connect: Europe summit
As the first EMA-approved microbiome-targeted therapeutics emerge on the horizon, drug developers will have the opportunity to benchmark their rational drug platforms, targeting validated pathways in gastrointestinal, neurological, metabolic disorders, as well as oncology-based indications.
Furthermore, separate tracks will be committed to developing novel, clinical-validated product formulations for nutritional, digestive wellness, oral and skin care applications.
Join us to hear from microbiome biotechs, pharma voices, investment bodies, consumer product brands, and more on how to develop robust, scalable, and reproducible formulations for microbe-derived/-targeting products entering late-stage investigations and reaching for the market.
3rd Conference on Food Bioactives & Health
Microbiome Connect: Gut Therapeutics
If you are trying to understand the gut microbiome on a metabolic, mechanistic level in order to develop small molecule, single strain, or consortia, come and join our expert speaking faculty of academic and industry leaders as they share the latest pre/clinical data, which could upskill your manufacturing capabilities to meet clinical and market demand.